- Home
- MHH vs INM Comparison
MHH vs INM Comparison
Compare MHH & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MHH
- INM
- Stock Information
- Founded
- MHH 1986
- INM 1981
- Country
- MHH United States
- INM Canada
- Employees
- MHH N/A
- INM N/A
- Industry
- MHH Professional Services
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- MHH Consumer Discretionary
- INM Health Care
- Exchange
- MHH Nasdaq
- INM Nasdaq
- Market Cap
- MHH 78.2M
- INM 3.2M
- IPO Year
- MHH N/A
- INM N/A
- Fundamental
- Price
- MHH $7.04
- INM $3.05
- Analyst Decision
- MHH
- INM
- Analyst Count
- MHH 0
- INM 0
- Target Price
- MHH N/A
- INM N/A
- AVG Volume (30 Days)
- MHH 14.3K
- INM 5.8M
- Earning Date
- MHH 08-06-2025
- INM 05-12-2025
- Dividend Yield
- MHH N/A
- INM N/A
- EPS Growth
- MHH N/A
- INM N/A
- EPS
- MHH 0.17
- INM N/A
- Revenue
- MHH $200,437,000.00
- INM $4,920,990.00
- Revenue This Year
- MHH $1.22
- INM N/A
- Revenue Next Year
- MHH $5.41
- INM N/A
- P/E Ratio
- MHH $43.02
- INM N/A
- Revenue Growth
- MHH 3.93
- INM N/A
- 52 Week Low
- MHH $6.20
- INM $1.72
- 52 Week High
- MHH $16.00
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- MHH 50.16
- INM 51.64
- Support Level
- MHH $6.60
- INM $3.32
- Resistance Level
- MHH $6.85
- INM $5.50
- Average True Range (ATR)
- MHH 0.43
- INM 0.37
- MACD
- MHH 0.10
- INM 0.04
- Stochastic Oscillator
- MHH 46.77
- INM 24.38
About MHH Mastech Digital Inc
Mastech Digital Inc is a provider of Digital Transformation IT Services. The Company offers data & analytics solutions & IT staffing services for both digital & mainstream technologies. The Group has two segments. Its Data & Analytics Services segment delivers specialized data management, data engineering, customer experience consulting, data analytics & cloud services to customers globally. IT Staffing Services segment combines technical expertise with business process experience to deliver a broad range of services in digital & mainstream technologies. The company derives a majority of its revenue from IT staffing services. Geographically, the majority of revenue is generated from the United States.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.